Search Results for

GO43104

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer (IMforte)

Continue Reading »

---

NRG-CC009

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Continue Reading »

---

GO41767

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (SKYSCRAPER-02)

Continue Reading »

---

C2321001

PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (6)    Metastatic  (3)    Neoadjuvant  (2) Brain  (9)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (7)    Breast Cancer Adjuvant  (2)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (23) Carcinoid Tumors  (1) Colorectal Cancer  (8)    Metastatic  (2)    Rectal Neoadjuvant  (1) Esophageal Cancer  (1) Gall Bladder/ Biliary Tract Cancer  (1) Head/Neck Cancer  (6) Leukemia  (1)    Acute Myeloid Leukemia (AML)  (1) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (22)    Non-Small Cell Lung Cancer  (16)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (4)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (3)       Adjuvant Treatment for Resected NSCLC  (4)    Small Cell Lung Cancer  (6)       Extensive Stage SCLC  (4) Lymphoma  (2)    Non-Hodgkin’s Lymphoma  (1) MDS  (1) Melanoma  (1) Merkel Cell Carcinoma  (1) Multiple Myeloma  (2) Ovarian  (1) Pancreatic  (5)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (3) Sarcoma  (2)